, Volume 4, Issue 1, pp 14–30 | Cite as

The Economic Costs of Asthma

A Review and Conceptual Model
  • Kevin B. Weiss
  • Sean D. Sullivan
Review Article


There is a growing international concern about increasing asthma morbidity. While much is known about asthma morbidity, there are few available data on the economic burden of this condition, particularly in underdeveloped countries. In the absence of data on social costs, it is not possible to develop rational approaches to policies regarding resource allocation to reduce morbidity. The purpose of this article is to provide a review of the available literature on the social costs of illness for asthma. In light of this literature, we propose a conceptual model that links asthma morbidity to the social opportunity costs of the disease. We then delineate a framework, based on the proposed model, that can be used to conceptualise and evaluate the relative impact of alternative asthma intervention strategies. Based upon proposed analyses using this model, we believe that it would be possible to compare how various intervention strategies are likely to affect asthma costs and morbidity, thus providing a means for a more rational approach to healthcare policies regarding societal resource allocation for asthma.


Asthma Social Cost Childhood Asthma Direct Medical Cost Asthma Prevalence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Action Asthma. The occurrence and cost of asthma, Cambridge Medical Publications. West Sussex, 1990Google Scholar
  2. Asher MJ, Pattemore PK, Harrison AC, Mitchell EA, Rea HH, et al. International comparison of the prevalence of asthma symptoms and bronchial hyperresponsiveness. American Review of Respiratory Disease 138: 524–529, 1988PubMedGoogle Scholar
  3. Australlian Bureau of Statistics. Australian Health Survey: illness conditions experienced. Catalog no. 4356.0, Australian Bureau of Statistics. Canberra, 1983Google Scholar
  4. Burrows B. The natural history of asthma. Journal of Allergy and Clinical immunology 80: 313–386, 1987CrossRefGoogle Scholar
  5. Bryan S, Buxton MJ. Economic evaluation of treatments for respiratory disease. Pharmacoeconomics 2; 201–218, 1992CrossRefGoogle Scholar
  6. Carr W, Zeitel L, Weiss KB. Variations in asthma hospitalizations and deaths in New York city. American Journal of Public Health 82: 59–65, 1992PubMedCrossRefGoogle Scholar
  7. Cookson JB. Prevalence rates of asthma in developing countries and their comparison with those in Europe and North America. Chest 91 (Suppl.): 975–1035, 1987Google Scholar
  8. Cooper BS, Rice DP. The economic cost of illness revisited. Social Security Bulletin 39: 21, 1976PubMedGoogle Scholar
  9. Creer TL, Stein REK, Rappaport L, Lewis C. Behavioral consequences of illness: Childhood asthma as a model. Pediatrics 90: 808–815, 1992PubMedGoogle Scholar
  10. Davey PJ, Leeder SR. The cost of migraine: mort than just a headache? Pharmacoeconomics 2: 5–7, 1992PubMedCrossRefGoogle Scholar
  11. Donabedian A, Wheeler JRC, Wyszewianski L. Quality, cost, and health: An integrative model. Medial Care 20: 975–992, 1982CrossRefGoogle Scholar
  12. Drummond MF. Cost–of–illness studies: a major headache? Pharmacoeconomics 2: 1–4, 1992PubMedCrossRefGoogle Scholar
  13. Drummond MF, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes, Oxford Medical Publications, Oxford, 1987Google Scholar
  14. Evans III R, Mullally DI, Wilson RW, et al. National trends in the morbidity and mortality of asthma in the US: prevalence,hospitalization, and death from asthma over two decades: 1965-1984. Chest 91 (Suppl.): 65S–74S, 1987Google Scholar
  15. Fleming DM, Crombie DL. Prevalence of asthma and hay fever in England and Wales. British Medical Journal 294: 279–283, 1987PubMedCrossRefGoogle Scholar
  16. French MT, Mauskopf JA. A quality–of–life method for estimating the value of avoided morbidity. American Journal of Public Health 82: 1553–1555, 1992PubMedCrossRefGoogle Scholar
  17. Gellert AR, Gellert SL, Iliffe SR. Prevalence and management of asthma in a London inner city general practice. British Journal of General Practice 40: 197–201, 1990PubMedGoogle Scholar
  18. Gergen PJ, Mullally DJ, Evans R. National survey of prevalence of asthma among children in the United States, 1976-1980. Pediatrics 81: 1–7, ]988PubMedGoogle Scholar
  19. Gergen PJ, Weiss KB. Changing patterns of asthma hospitalization among children: 1979 to 1987. Journal of the American Medical Association 264: 1688–1692, 1990PubMedCrossRefGoogle Scholar
  20. Halfon N, Newacheck PW. Trends in the hospitalization for acute childhood asthma, 1970-1984. American Journal of Public Health 76: 1308–1311, 1986PubMedCrossRefGoogle Scholar
  21. Hodgson TA. Cigarette smoking and lifetime medical expenditures. Milbank Quarterly 70: 81–120, 1992PubMedCrossRefGoogle Scholar
  22. Hodgson TA, Meiners MR. Cost–of–illness methodology; a guide to current practices and procedures. Milbank Memorial Fund Quarterly/Health and Society 60: 429–462, 1982CrossRefGoogle Scholar
  23. Hodgson TA. The state of the art of cost–of–illness estimates. Advances in Health Economic and Health Services Research 4: 129–164, 1983Google Scholar
  24. Howland J, Bauchner H, Adair R. The impact of pediatric asthma education on morbidity. Chest 94: 964–969, 1988PubMedCrossRefGoogle Scholar
  25. Hu TW, Sandifer FH. Synthesis of cost–of–illness methodology, National Center for Health Services Research. Contract No.233-79-3010. Public Services Laboratory, Georgetown University Washington, DC, 1981Google Scholar
  26. Jackson R, Sears MR, Beaglehole R, Rea HH. Intemational trends in asthma mortality: 1970-1985. Chest 94: 914–919, 1988PubMedCrossRefGoogle Scholar
  27. Mackowiak JI, Boyer JG. Economic impact of asthma on school and work productivity. 1st National Conference on Asthma Management, Arlington, VA, October 1992Google Scholar
  28. Katz DA, Welch HG. Discounting in cost–effectiveness analysisof healthcare programmes. Pharmacoeconomics 3: 276–285, 1993PubMedCrossRefGoogle Scholar
  29. Marion RJ, Creer TL, Reynolds RVC. Direct and indirect costs associated with the management of childhood asthma. Annals of Allergy 54: 31–34, 1985PubMedGoogle Scholar
  30. McFadden Jr ER. Asthma. In Harrison’s Principles of Internal Medicine, 12th ed., McGraw-Hill, New York, NY, 1991Google Scholar
  31. Mellis CM, Peat JK, Bauman AE, Woolcock AJ. The cost of asthma in New South Wales. Medical Journal of Australia 155: 522–528, 1991PubMedGoogle Scholar
  32. Mellis CM, Peat JK, Woolcock A. The cost of asthma: can it be reduced? Pharmacoeconomics 3: 205–219, 1993PubMedCrossRefGoogle Scholar
  33. Mitchell EA. Increasing prevalence of asthma in children. New Zealand Journal of Medicine 96: 463–464, 1983Google Scholar
  34. Mitchell EA. International trends in hospital admission rates for asthma. Archives of Disease of Childhood 60: 376–378, 1985CrossRefGoogle Scholar
  35. Mushkin SJ, Dunlop DW. Health: What is it worth? Measuring of health benefit. Pergamon Press, Elmsford. NY, 1979Google Scholar
  36. Paringer L, Berk A. Costs of illness and disease fiscal year 1975. Report No.2. Public Services Laboratory, Georzetown University,Washington, DC, 1977Google Scholar
  37. Patrick DL, Bergner M. Measurement of Health Status in the 1990s. Annual Review of Public Health 11: 16583, 1990CrossRefGoogle Scholar
  38. Rice DP. Estimating the cost of illness. Health Economics Series N0. 6. Publicatilln No. 947-6. US Government Printing Office,Washington, DC, 1966Google Scholar
  39. Rice DP, Hodgson TA. The value of human life revisited. American Journal of Public Health 72: 536–538, 1982PubMedCrossRefGoogle Scholar
  40. Rice DP, Hodgson TA, Kopstein AN. The economic costs of illness: A replication and update. Health Care Financing Review 7: 61–80, 1985PubMedGoogle Scholar
  41. Robinson JC. Philosophical origins of the economic valuation of life. Milbank Quarterly 64: 133–155, 1986PubMedCrossRefGoogle Scholar
  42. Ross RN. The Cost of managing asthma. Journal of Respiratory Disease 21 (Suppl.): S15–S20, 1988Google Scholar
  43. Rutten Van-Molken MPMH, Van Doorslaer EKA, Rutten FFH. Economic appraisal of asthma and COPD care: a literature review 1980-1991. Social Science and Medicine 35: 161–175, 1992CrossRefGoogle Scholar
  44. Stein REK, Gortmaker SL, Perrin EC, Pless IB, Walker DK, et al. Severity of illness: concepts and measurement. Lancet 2: 1506–1509, 1987PubMedCrossRefGoogle Scholar
  45. Taylor WR, Newacheck PW. Impact of childhood asthma on health. Pediatrics 90: 657–662, 1992PubMedGoogle Scholar
  46. Thompson S. Astmasjukdomens samhallsckonomiska kostnader. The Swedish Institute for Health Economics IHE Meddelande 8, Lund, 1981Google Scholar
  47. US National Heart and Lung Institute. Respiratory diseases: Task force report on problems, research approaches, and needs. Department of Health, Education and Welfare Publication No.(NIH) 76-432. US National Institutes of Health, Washington DC, 1972Google Scholar
  48. Vance VJ, Taylor WF. The financial cost of chronic childhood asthma. Annals of Allergy 29: 455–460, 1971PubMedGoogle Scholar
  49. Vollmer WM, Osborne ML, Buist AS. Temporal trends in haspital–based episodes of asthma care in a health maintenance organisation Clinical measure of outcome. American Reviews of Respiratory Disease 147: 347–353, 1993Google Scholar
  50. Weir DC, Robertson AS, Jones S, Burge PS. The economic consequences of developing occupational asthma. Thorax 42: 209, 1987Google Scholar
  51. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. New England Journal of Medicine 326: 862–866, 1992PubMedCrossRefGoogle Scholar
  52. Weiss KB, Wegener DK. Geographic variation in US asthma mortality; small–area analyses of excess mortality 1981-1985. American Journal of Epidemiology 132 (Suppl.): 5I07–5115, 1990Google Scholar
  53. Weitzman M, Gortmaker SL, Sobol AM, Perrin JM. Resent trends in the prevalence and severity of childhood asthma. Journal of the American Medical Association 268: 2673–2677, 1992PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1993

Authors and Affiliations

  • Kevin B. Weiss
    • 1
  • Sean D. Sullivan
    • 2
  1. 1.Departments of Health Care Sciences and Medicine and the Center for Health Policy ResearchThe George Washington UniversityUSA
  2. 2.Departments of Pharmacy and Health Services, Schools of Pharmacy and Public Health and Community Medicine, and Program in Pharmacoepidemiology and Drug PolicyUniversity of WashingtonSeattleUSA

Personalised recommendations